Resources

The cellular decision to progress past the G1\text{G}_1 restriction point depends on the net balance between active CDK4/6-Cyclin D complexes (which promote division) and Cyclin-Dependent Kinase Inhibitors (CKIs, such as p21CIP1\text{p}21^{\text{CIP1}} and p16INK4a\text{p}16^{\text{INK4a}}). Let the intracellular phosphorylation rate of pRb\text{pRb} be modeled by the net kinetic balance d[pRb-P]dt=kact[CDK4]−kinh[CKI]\frac{d[\text{pRb-P}]}{dt} = k_{\text{act}}[\text{CDK4}] - k_{\text{inh}}[\text{CKI}]. In normal resting cells, kact=0.050 s−1k_{\text{act}} = 0.050\text{ s}^{-1} with [CDK4]=40.0 nM[\text{CDK4}] = 40.0\text{ nM}, while DNA-damage-induced p53\text{p53} maintains [CKI]=60.0 nM[\text{CKI}] = 60.0\text{ nM} with kinh=0.045 s−1k_{\text{inh}} = 0.045\text{ s}^{-1}, yielding a negative net rate convention (d[pRb-P]dt<0\frac{d[\text{pRb-P}]}{dt} < 0), enforcing cell cycle arrest. In a malignant cell line, an oncogenic mutation causes a two-fold amplification of [CDK4][\text{CDK4}] alongside a loss-of-function mutation in TP53\text{TP53} that reduces [CKI][\text{CKI}] by 75.0%75.0\%. Calculate the normal initial net rate (d[pRb-P]dt)norm\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{norm}} and the transformed net rate (d[pRb-P]dt)cancer\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{cancer}} in nM/s\text{nM}/\text{s}, and explicitly state whether the sign convention in the cancer line indicates net forward cell cycle progression or arrest.

Answer and steps

Final answer

(d[pRb-P]dt)norm=−0.700 nM/s\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{norm}} = -0.700\text{ nM}/\text{s} (arrest); (d[pRb-P]dt)cancer=+3.325 nM/s\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{cancer}} = +3.325\text{ nM}/\text{s} (positive sign indicates net phosphorylation and forward cell cycle progression past the restriction point).

Steps

01

Calculate the Normal Initial Net Rate (d[pRb-P]dt)norm\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{norm}}

Biological Context and Rate Equation

The G1/S\text{G}_1/\text{S} restriction point acts as a critical molecular gate in the cell cycle. Phosphorylation of the retinoblastoma protein (pRb\text{pRb}) by active CDK4/6-Cyclin D\text{CDK4/6-Cyclin D} complexes releases the E2F\text{E2F} transcription factor, driving entry into the S\text{S} phase. Conversely, cyclin-dependent kinase inhibitors (CKIs\text{CKIs}) like p21\text{p}21 and p16\text{p}16 suppress this kinase activity to maintain cell cycle arrest. The net rate of pRb\text{pRb} phosphorylation is given by the kinetic equation: d[pRb-P]dt=kact[CDK4]−kinh[CKI]\frac{d[\text{pRb-P}]}{dt} = k_{\text{act}}[\text{CDK4}] - k_{\text{inh}}[\text{CKI}]

Substitute the parameters for resting, unperturbed cells:

  • kact=0.050 s−1k_{\text{act}} = 0.050\text{ s}^{-1}
  • [CDK4]norm=40.0 nM[\text{CDK4}]_{\text{norm}} = 40.0\text{ nM}
  • kinh=0.045 s−1k_{\text{inh}} = 0.045\text{ s}^{-1}
  • [CKI]norm=60.0 nM[\text{CKI}]_{\text{norm}} = 60.0\text{ nM}

(d[pRb-P]dt)norm=(0.050 s−1)(40.0 nM)−(0.045 s−1)(60.0 nM)\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{norm}} = (0.050\text{ s}^{-1})(40.0\text{ nM}) - (0.045\text{ s}^{-1})(60.0\text{ nM}) (d[pRb-P]dt)norm=2.000 nM/s−2.700 nM/s=−0.700 nM/s\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{norm}} = 2.000\text{ nM/s} - 2.700\text{ nM/s} = -0.700\text{ nM/s}

A negative net rate (d[pRb-P]dt<0\frac{d[\text{pRb-P}]}{dt} < 0) indicates that inhibitory activity dominates, preventing pRb\text{pRb} phosphorylation and keeping the cell arrested at the G1\text{G}_1 checkpoint.


02

Determine Concentrations in the Transformed Malignant Cell Line

  1. Amplified Kinase Concentration: A two-fold amplification of CDK4\text{CDK4} yields: [CDK4]cancer=2⋅40.0 nM=80.0 nM[\text{CDK4}]_{\text{cancer}} = 2 \cdot 40.0\text{ nM} = 80.0\text{ nM}
  2. Depleted Inhibitor Concentration:

    Common Pitfall: A reduction by 75.0%75.0\% leaves 25.0%25.0\% (100%−75.0%100\% - 75.0\%) of the original concentration remaining, rather than 75.0%75.0\%.

    [CKI]cancer=60.0 nM⋅(1−0.750)=60.0 nM⋅0.250=15.0 nM[\text{CKI}]_{\text{cancer}} = 60.0\text{ nM} \cdot (1 - 0.750) = 60.0\text{ nM} \cdot 0.250 = 15.0\text{ nM}


03

Calculate the Transformed Net Rate (d[pRb-P]dt)cancer\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{cancer}}

Using the unchanged kinetic rate constants kact=0.050 s−1k_{\text{act}} = 0.050\text{ s}^{-1} and kinh=0.045 s−1k_{\text{inh}} = 0.045\text{ s}^{-1}:

(d[pRb-P]dt)cancer=(0.050 s−1)(80.0 nM)−(0.045 s−1)(15.0 nM)\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{cancer}} = (0.050\text{ s}^{-1})(80.0\text{ nM}) - (0.045\text{ s}^{-1})(15.0\text{ nM}) (d[pRb-P]dt)cancer=4.000 nM/s−0.675 nM/s=+3.325 nM/s\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{cancer}} = 4.000\text{ nM/s} - 0.675\text{ nM/s} = +3.325\text{ nM/s}


04

Biological Interpretation of the Sign Convention

  • Normal Cells (−0.700 nM/s-0.700\text{ nM/s}): The negative sign denotes net dephosphorylated or unphosphorylated pRb\text{pRb} dominance, enforcing cell cycle arrest.
  • Cancer Cells (+3.325 nM/s+3.325\text{ nM/s}): The positive sign indicates active, continuous net phosphorylation of pRb\text{pRb} (pRb-P\text{pRb-P} accumulation), releasing E2F\text{E2F} and propelling uncontrolled forward progression past the restriction point into S\text{S} phase.

Typical errors

OverviewACEpath Teacher's Diagnosis

01 The student misinterprets a 75% reduction as retaining 75% of the initial CKI concentration, setting [CKI] to 45.0 nM instead of 15.0 nM.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    d[pRb-P]dt=kact[CDK4]−kinh[CKI]=(0.050)(40.0)−(0.045)(60.0)=2.00−2.70=−0.70 nM/s\frac{d[\text{pRb-P}]}{dt} = k_{\text{act}}[\text{CDK4}] - k_{\text{inh}}[\text{CKI}] = (0.050)(40.0) - (0.045)(60.0) = 2.00 - 2.70 = -0.70\text{ nM/s}

  2. Step 2

    [CDK4]=2×40.0=80.0 nM  ⟹  [CKI]=0.750×60.0=45.0 nM[\text{CDK4}] = 2 \times 40.0 = 80.0\text{ nM} \implies [\text{CKI}] = 0.750 \times 60.0 = 45.0\text{ nM}

    Correct

    [CDK4]cancer=2×40.0=80.0 nM  ⟹  [CKI]cancer=60.0×(1−0.750)=15.0 nM[\text{CDK4}]_{\text{cancer}} = 2 \times 40.0 = 80.0\text{ nM} \implies [\text{CKI}]_{\text{cancer}} = 60.0 \times (1 - 0.750) = 15.0\text{ nM}

    A loss-of-function mutation that reduces [CKI][\text{CKI}] by 75.0%75.0\% leaves 100%−75.0%=25.0%100\% - 75.0\% = 25.0\% of the inhibitor remaining, so the final concentration is 60.0 nM×0.250=15.0 nM60.0\text{ nM} \times 0.250 = 15.0\text{ nM} rather than 45.0 nM45.0\text{ nM}.

  3. Step 3

    d[pRb-P]dt=(0.050)(80.0)−(0.045)(45.0)=4.00−2.025=1.975 nM/s\frac{d[\text{pRb-P}]}{dt} = (0.050)(80.0) - (0.045)(45.0) = 4.00 - 2.025 = 1.975\text{ nM/s}

    Correct

    (d[pRb-P]dt)cancer=(0.050)(80.0)−(0.045)(15.0)=4.000−0.675=+3.325 nM/s\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{cancer}} = (0.050)(80.0) - (0.045)(15.0) = 4.000 - 0.675 = +3.325\text{ nM/s}

    Your kinetic calculation followed your substituted value of [CKI]=45.0 nM[\text{CKI}] = 45.0\text{ nM} consistently, but the numerical result was thrown off by the earlier percentage error.

  4. Step 4

    Forward cell cycle progression\text{Forward cell cycle progression}

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly applied the net kinetic balance equation for both physiological conditions.

You accurately calculated the normal net rate of −0.70 nM/s-0.70\text{ nM/s}.

You correctly handled the two-fold amplification of [CDK4][\text{CDK4}] as 80.0 nM80.0\text{ nM}.

You accurately interpreted the sign convention, recognizing that a positive rate signals forward cell cycle progression.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Percentage Reduction vs. Retention Trap

You treated a 75.0%75.0\% reduction as retaining 75.0%75.0\% of the original concentration instead of 25.0%25.0\%.

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

Conflating 'reduced by x%x\%' with 'reduced to x%x\%' or 'retains x%x\%'. A quantity reduced by x%x\% retains a fraction of (1−x/100)(1 - x/100).

REASONING PATH
Your ACEpath teacher’s suggested approach
'Reduced by' vs. 'Reduced to'
  • If a quantity AA is reduced by P%P\%, the remaining amount is Anew=A×(1−P/100)A_{\text{new}} = A \times (1 - P/100). If it is reduced to P%P\%, then Anew=A×(P/100)A_{\text{new}} = A \times (P/100).

  • Whenever you encounter the phrase 'reduced by X%X\%', write out (1−X/100)(1 - X/100) before calculating.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Calculate the remaining inhibitor concentration after a 75.0%75.0\% reduction: [CKI]cancer=60.0 nM×(1−0.750)=15.0 nM[\text{CKI}]_{\text{cancer}} = 60.0\text{ nM} \times (1 - 0.750) = 15.0\text{ nM}.

  2. Substitute [CDK4]=80.0 nM[\text{CDK4}] = 80.0\text{ nM} and [CKI]=15.0 nM[\text{CKI}] = 15.0\text{ nM} into the rate equation: (d[pRb-P]dt)cancer=(0.050)(80.0)−(0.045)(15.0)\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{cancer}} = (0.050)(80.0) - (0.045)(15.0).

  3. Evaluate the terms: 4.000 nM/s−0.675 nM/s=+3.325 nM/s4.000\text{ nM/s} - 0.675\text{ nM/s} = +3.325\text{ nM/s}.

Final answer

(d[pRb-P]dt)norm=−0.700 nM/s\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{norm}} = -0.700\text{ nM/s} (arrest); (d[pRb-P]dt)cancer=+3.325 nM/s\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{cancer}} = +3.325\text{ nM/s} (forward cell cycle progression past the G1\text{G}_1 restriction point).

NEXT STEPS
Final Takeaways from Your Teacher
  • Always write out (1−fraction)(1 - \text{fraction}) when a biological concentration is reduced by a given percentage.

  • Rework the transformed rate calculation using [CKI]=15.0 nM[\text{CKI}] = 15.0\text{ nM} to confirm +3.325 nM/s+3.325\text{ nM/s}.

OverviewACEpath Teacher's Diagnosis

02 The student confuses the roles of activation and inhibition, reversing the subtraction order in the kinetic balance equation.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Incorrect
  1. Step 1

    dpRb-Pdt\frac{\text{pRb-P}}{dt} = k_{inh\text{inh}}[CKI\text{CKI}] - k_{act\text{act}}[CDK4\text{CDK4}]   ⟹  \implies = (0.045)(60.0) - (0.050)(40.0)   ⟹  \implies = 2.70 - 2.00 = 0.70 nM/s\text{ nM/s}

    Correct

    (d[pRb-P]dt)\left(\frac{d[\text{pRb-P}]}{dt}\right){norm\text{norm}} = k{act\text{act}}[CDK4\text{CDK4}] - k_{inh\text{inh}}[CKI\text{CKI}] = (0.050)(40.0) - (0.045)(60.0) = -0.700 nM/s\text{ nM/s}_

    You reversed the terms in the rate formula. The problem states that CDK4/6 promotes division by phosphorylating pRb, so the activating term kact[CDK4]k_{\text{act}}[\text{CDK4}] carries a positive sign, while the inhibitor term kinh[CKI]k_{\text{inh}}[\text{CKI}] is subtracted.

  2. Step 2

    [CDK4\text{CDK4}] = 2 ×\times 40.0 = 80.0 nM\text{ nM}   ⟹  \implies [CKI\text{CKI}] = 60.0 ×\times 0.250 = 15.0 nM\text{ nM}

  3. Step 3

    dpRb-Pdt\frac{\text{pRb-P}}{dt} = (0.045)(15.0) - (0.050)(80.0)   ⟹  \implies = 0.675 - 4.00 = -3.325 nM/s\text{ nM/s}

    Correct

    (d[pRb-P]dt)\left(\frac{d[\text{pRb-P}]}{dt}\right){cancer\text{cancer}} = (0.050)(80.0) - (0.045)(15.0) = 4.000 - 0.675 = +3.325 nM/s\text{ nM/s}

    Your arithmetic was accurate for your expressions, but because the formula was set up in reverse, the resulting cancer rate took on a negative sign instead of +3.325 nM/s+3.325\text{ nM/s}.

  4. Step 4

    Cell cycle arrest\text{Cell cycle arrest}

    Correct

    Positive sign indicates net forward cell cycle progression past the restriction point\text{Positive sign indicates net forward cell cycle progression past the restriction point}

    Because your calculated rate for the malignant cell line was negative, you concluded arrest. With the correct positive rate (+3.325 nM/s+3.325\text{ nM/s}), net pRb phosphorylation releases E2F, driving uncontrolled forward progression into S phase.

WHAT YOU DID WELL
Compliments from Your Teacher

You accurately identified and applied the twofold amplification factor to double the CDK4 concentration.

You correctly calculated the remaining CKI concentration by taking 25.0%25.0\% after a 75.0%75.0\% reduction.

You performed the individual multiplication and subtraction steps accurately according to your written expressions.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Reversed Kinetic Balance Formula

You swapped the activating and inhibiting components when setting up the net phosphorylation rate equation.

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You associated the inhibitor term with positive accumulation rather than recognizing that active CDK4 drives phosphorylation of pRb (positive contribution), while CKIs oppose and suppress this phosphorylation (negative contribution).

REASONING PATH
Your ACEpath teacher’s suggested approach
Kinetic Sign Convention
  • Net rate of product accumulation = (Formation/Activation rate) − (Loss/Inhibition rate).

  • Always assign a positive sign to the factor promoting product formation (CDK4 forming pRb-P) and subtract the opposing factor (CKI).

Biological Reality Check
  • Malignant cancer cells overcome checkpoints and undergo uncontrolled division, which requires hyperphosphorylation of pRb (positive rate).

  • Verify that your final net rate for a cancer line is positive, consistent with checkpoint bypass.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Substitute the mutated concentrations into the correct kinetic balance: (d[pRb-P]dt)cancer=kact[CDK4]cancer−kinh[CKI]cancer\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{cancer}} = k_{\text{act}}[\text{CDK4}]_{\text{cancer}} - k_{\text{inh}}[\text{CKI}]_{\text{cancer}}.

  2. Evaluate numerically: (0.050 s−1)(80.0 nM)−(0.045 s−1)(15.0 nM)=4.000 nM/s−0.675 nM/s=+3.325 nM/s(0.050\text{ s}^{-1})(80.0\text{ nM}) - (0.045\text{ s}^{-1})(15.0\text{ nM}) = 4.000\text{ nM/s} - 0.675\text{ nM/s} = +3.325\text{ nM/s}.

  3. Interpret the sign: the positive net rate indicates net accumulation of phosphorylated pRb, releasing E2F transcription factors to drive forward cell cycle progression past the G1\text{G}_1 restriction point.

Final answer

(d[pRb-P]dt)norm=−0.700 nM/s\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{norm}} = -0.700\text{ nM/s} (arrest); (d[pRb-P]dt)cancer=+3.325 nM/s\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{cancer}} = +3.325\text{ nM/s} (forward progression)

NEXT STEPS
Final Takeaways from Your Teacher
  • Review how pRb phosphorylation by CDK4/6 leads to E2F release and entry into S phase.

  • Practice setting up kinetic balance equations by identifying the direct promoter of the target species first.

  • Complete the targeted flashcards and transfer exercises below to reinforce sign conventions in cell cycle regulation.

OverviewACEpath Teacher's Diagnosis

03 The student misinterprets a two-fold amplification as adding two times the original concentration rather than doubling it, resulting in 120.0 nM CDK4.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    d[pRb-P]dt=(0.050)(40.0)−(0.045)(60.0)=2.00−2.70=−0.70 nM/s\frac{d[\text{pRb-P}]}{dt} = (0.050)(40.0) - (0.045)(60.0) = 2.00 - 2.70 = -0.70\text{ nM/s}

  2. Step 2

    [CDK4]=120.0 nM  ⟹  [CKI]=60.0×0.250=15.0 nM[\text{CDK4}] = 120.0\text{ nM} \implies [\text{CKI}] = 60.0 \times 0.250 = 15.0\text{ nM}

    Correct

    [CDK4]cancer=2×40.0 nM=80.0 nM  ⟹  [CKI]cancer=60.0 nM×(1−0.750)=15.0 nM[\text{CDK4}]_{\text{cancer}} = 2 \times 40.0\text{ nM} = 80.0\text{ nM} \implies [\text{CKI}]_{\text{cancer}} = 60.0\text{ nM} \times (1 - 0.750) = 15.0\text{ nM}

    While you correctly handled the 75.0%75.0\% reduction for [CKI][\text{CKI}], a "two-fold amplification" means multiplying the baseline concentration by 22 (2×40.0 nM=80.0 nM2 \times 40.0\text{ nM} = 80.0\text{ nM}), not adding twice the original concentration to itself (40.0+80.0=120.0 nM40.0 + 80.0 = 120.0\text{ nM}).

  3. Step 3

    d[pRb-P]dt=(0.050)(120.0)−(0.045)(15.0)=6.00−0.675=5.325 nM/s\frac{d[\text{pRb-P}]}{dt} = (0.050)(120.0) - (0.045)(15.0) = 6.00 - 0.675 = 5.325\text{ nM/s}

    Correct

    (d[pRb-P]dt)cancer=(0.050)(80.0)−(0.045)(15.0)=4.000−0.675=+3.325 nM/s\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{cancer}} = (0.050)(80.0) - (0.045)(15.0) = 4.000 - 0.675 = +3.325\text{ nM/s}

    Your arithmetic was carried out correctly from your stated concentrations, but the result was altered by the incorrect [CDK4][\text{CDK4}] value from Step 2.

  4. Step 4

    Forward cell cycle progression\text{Forward cell cycle progression}

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly evaluated the normal cell rate and units as −0.70 nM/s-0.70\text{ nM/s}.

You correctly handled the phrase "reduces by 75.0%75.0\%" by multiplying by (1−0.750)=0.250(1 - 0.750) = 0.250 to get 15.0 nM15.0\text{ nM}.

You accurately interpreted that a positive net rate signifies forward cell cycle progression.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Fold-change vs additive increase confusion

Interpreting an "NN-fold amplification" as adding NN times the baseline rather than multiplying the baseline by NN.

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You confused a fold change/amplification factor (which is strictly multiplicative: NN-fold of XX is N⋅XN \cdot X) with a percentage increase or additive expansion (such as "increased by 200%200\%" or adding two additional copies to the existing baseline).

REASONING PATH
Your ACEpath teacher’s suggested approach
Interpreting Biological Fold Amplifications
  • An nn-fold amplification or change of baseline XX yields a new value of n⋅Xn \cdot X.

  • When encountering "nn-fold amplification", directly multiply the initial baseline concentration by nn; do not add it to the baseline.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. [CDK4]cancer=2×40.0 nM=80.0 nM[\text{CDK4}]_{\text{cancer}} = 2 \times 40.0\text{ nM} = 80.0\text{ nM}

  2. [CKI]cancer=60.0 nM×(1−0.750)=15.0 nM[\text{CKI}]_{\text{cancer}} = 60.0\text{ nM} \times (1 - 0.750) = 15.0\text{ nM}

  3. (d[pRb-P]dt)cancer=(0.050 s−1)(80.0 nM)−(0.045 s−1)(15.0 nM)=4.000 nM/s−0.675 nM/s=+3.325 nM/s\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{cancer}} = (0.050\text{ s}^{-1})(80.0\text{ nM}) - (0.045\text{ s}^{-1})(15.0\text{ nM}) = 4.000\text{ nM/s} - 0.675\text{ nM/s} = +3.325\text{ nM/s}

Final answer

(d[pRb-P]dt)norm=−0.700 nM/s (arrest);(d[pRb-P]dt)cancer=+3.325 nM/s (forward progression)\left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{norm}} = -0.700\text{ nM/s}\text{ (arrest)}; \left(\frac{d[\text{pRb-P}]}{dt}\right)_{\text{cancer}} = +3.325\text{ nM/s}\text{ (forward progression)}

NEXT STEPS
Final Takeaways from Your Teacher
  • Review biological terminology for concentration changes (fold-increase vs. percent-increase vs. fold-amplification).

  • Practice calculating net kinase/phosphatase balance equations with varying baseline parameter shifts.

Lock it in

Similar question

01

In a cell line undergoing DNA damage response, the baseline concentration of active kinase CDK2\text{CDK2} is 50.0 nM50.0\text{ nM}. Induced checkpoint signaling reduces active [CDK2][\text{CDK2}] by 60.0%60.0\%. What is the final concentration of active CDK2\text{CDK2}?

Answer

[CDK2]final=50.0 nM×(1−0.600)=50.0 nM×0.400=20.0 nM[\text{CDK2}]_{\text{final}} = 50.0\text{ nM} \times (1 - 0.600) = 50.0\text{ nM} \times 0.400 = 20.0\text{ nM}.

02

The net rate of cyclosome activation is modeled as R=kact[Cdc20]−kinh[Mad2]R = k_{\text{act}}[\text{Cdc20}] - k_{\text{inh}}[\text{Mad2}], with kact=0.080 s−1k_{\text{act}} = 0.080\text{ s}^{-1} and kinh=0.060 s−1k_{\text{inh}} = 0.060\text{ s}^{-1}. Initially, [Cdc20]=30.0 nM[\text{Cdc20}] = 30.0\text{ nM} and [Mad2]=50.0 nM[\text{Mad2}] = 50.0\text{ nM}. A checkpoint override mutation increases [Cdc20][\text{Cdc20}] by 50.0%50.0\% and decreases [Mad2][\text{Mad2}] by 80.0%80.0\%. Calculate the mutated net activation rate RR.

Answer
  1. New concentrations: [Cdc20]=30.0×1.50=45.0 nM[\text{Cdc20}] = 30.0 \times 1.50 = 45.0\text{ nM}; [Mad2]=50.0×(1−0.80)=10.0 nM[\text{Mad2}] = 50.0 \times (1 - 0.80) = 10.0\text{ nM}.\n2. Mutated rate: R=(0.080)(45.0)−(0.060)(10.0)=3.60−0.60=+3.00 nM/sR = (0.080)(45.0) - (0.060)(10.0) = 3.60 - 0.60 = +3.00\text{ nM/s}.
03

In normal tissue, the steady-state phosphorylation rate of an apoptotic gatekeeper protein is governed by d[P]dt=k1[Akt]−k2[PTEN]=0 nM/s\frac{d[P]}{dt} = k_1 [\text{Akt}] - k_2 [\text{PTEN}] = 0\text{ nM/s}, where k1=0.040 s−1k_1 = 0.040\text{ s}^{-1}, k2=0.020 s−1k_2 = 0.020\text{ s}^{-1}, and [PTEN]=100.0 nM[\text{PTEN}] = 100.0\text{ nM}. In a carcinoma, [Akt][\text{Akt}] undergoes a 33-fold amplification, while [PTEN][\text{PTEN}] is reduced by 90.0%90.0\%. Calculate the normal baseline [Akt][\text{Akt}] and the transformed net phosphorylation rate (d[P]dt)cancer\left(\frac{d[P]}{dt}\right)_{\text{cancer}}.

Answer
  1. Baseline: 0.040[Akt]−(0.020)(100.0)=0  ⟹  [Akt]=50.0 nM0.040[\text{Akt}] - (0.020)(100.0) = 0 \implies [\text{Akt}] = 50.0\text{ nM}.\n2. Cancer concentrations: [Akt]cancer=3×50.0=150.0 nM[\text{Akt}]_{\text{cancer}} = 3 \times 50.0 = 150.0\text{ nM}; [PTEN]cancer=100.0×(1−0.900)=10.0 nM[\text{PTEN}]_{\text{cancer}} = 100.0 \times (1 - 0.900) = 10.0\text{ nM}.\n3. Transformed rate: (d[P]dt)cancer=(0.040)(150.0)−(0.020)(10.0)=6.000−0.200=+5.800 nM/s\left(\frac{d[P]}{dt}\right)_{\text{cancer}} = (0.040)(150.0) - (0.020)(10.0) = 6.000 - 0.200 = +5.800\text{ nM/s}.
Loading workspace…